Morgan Stanley’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $111M | Sell |
|
|||||
|
2025
Q1 | $169M | Sell |
|
|||||
|
2024
Q4 | $329M | Buy |
|
|||||
|
2024
Q3 | $244M | Buy |
|
|||||
|
2024
Q2 | $214M | Buy |
|
|||||
|
2024
Q1 | $76.6M | Sell |
|
|||||
|
2023
Q4 | $172M | Buy |
|
|||||
|
2023
Q3 | $59.2M | Sell |
|
|||||
|
2023
Q2 | $52.3M | Buy |
|
|||||
|
2023
Q1 | $43.1M | Sell |
|
|||||
|
2022
Q4 | $57.4M | Buy |
|
|||||
|
2022
Q3 | $47M | Sell |
|
|||||
|
2022
Q2 | $44.1M | Buy |
|
|||||
|
2022
Q1 | $36.4M | Buy |
|
|||||
|
2021
Q4 | $28.7M | Buy |
|
|||||
|
2021
Q3 | $25.8M | Buy |
|
|||||
|
2021
Q2 | $23.5M | Buy |
|
|||||
|
2021
Q1 | $21.3M | Sell |
|
|||||
|
2020
Q4 | $24.2M | Buy |
|
|||||
|
2020
Q3 | $22.5M | Sell |
|
|||||
|
2020
Q2 | $32.4M | Sell |
|
|||||
|
2020
Q1 | $25.7M | Sell |
|
|||||
|
2019
Q4 | $54.8M | Buy |
|
|||||
|
2019
Q3 | $24.1M | Sell |
|
|||||
|
2019
Q2 | $64.7M | Buy |
|
|||||
|
2019
Q1 | $29.2M | Buy |
|
|||||
|
2018
Q4 | $24.3M | Sell |
|
|||||
|
2018
Q3 | $58.7M | Sell |
|
|||||
|
2018
Q2 | $111M | Buy |
|
|||||
|
2018
Q1 | $65.5M | Sell |
|
|||||
|
2017
Q4 | $122M | Buy |
|
|||||
|
2017
Q3 | $109M | Sell |
|
|||||
|
2017
Q2 | $233M | Sell |
|
|||||
|
2017
Q1 | $273M | Buy |
|
|||||
|
2016
Q4 | $261M | Sell |
|
|||||
|
2016
Q3 | $402M | Buy |
|
|||||
|
2016
Q2 | $141M | Sell |
|
|||||
|
2016
Q1 | $162M | Buy |
|
|||||
|
2015
Q4 | $106M | Buy |
|
|||||
|
2015
Q3 | $90.2M | Sell |
|
|||||
|
2015
Q2 | $124M | Sell |
|
|||||
|
2015
Q1 | $137M | Buy |
|
|||||
|
2014
Q4 | $99.4M | Sell |
|
|||||
|
2014
Q3 | $106M | Buy |
|
|||||
|
2014
Q2 | $92.7M | Buy |
|
|||||
|
2014
Q1 | $91.5M | Sell |
|
|||||
|
2013
Q4 | $110M | Buy |
|
|||||
|
2013
Q3 | $91.8M | Buy |
|
|||||
|
2013
Q2 | $93.5M | Buy |
|